|« Previous month||Next month »|
31-Jul-2012 - Industrial gas supplier Linde claims its 'cryogenic fog' technology is the first commercially-feasible way of controlling ice-crystal formation during the lyophilisation of biologic drugs.
31-Jul-2012 - Granules India saw API sales rocket in the fiscal first quarter due – according to the firm – to an efficiency drive and the impact of rising prices in China.
31-Jul-2012 - Reformulation and delivery tech firm SkyPharma is set for an earnings boost following US approval for rheumatoid arthritis (RA) drug developed by Horizon Pharma.
31-Jul-2012 - Eli Lilly plans to double its insulin and device manufacturing capacity by 2017 without building any new production plants.
30-Jul-2012 - BASF has changed what it charges for ethanolamines (EOA) in Europe for the third time this year.
30-Jul-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest chops and changes on the pharmaceutical careers ladder, including news from ABPI, Cubist and Oxford Pharmascience.
30-Jul-2012 - Pharmas producing drugs for the Australian market may see manufacturing licence charges slashed if their products do not sell above a certain threshold according to a plan outlined by the...
30-Jul-2012 - Researchers at SRI International say a bioadhesive-based platform delivery could help slow the spread of HIV and HSV in Africa.
26-Jul-2012 - Teva Pharmaceuticals is set to build its first Indian production plant after finalising a pact with healthcare giant Procter & Gamble (P&G), according to local authorities.
26-Jul-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest new hires in the pharmaceutical industry, including news from the FDA, Cipla and Array.
26-Jul-2012 - Cherwell Laboratories has more than doubled the size of its Bicester, UK, plant that manufactures prepared media for microbial production after a boom in demand for its goods.
26-Jul-2012 - Variable understanding of QbD among US FDA reviewers is leading to mixed messages and confusion, a consultant said.
25-Jul-2012 - Sigma Aldrich’s fine chemicals manufacturing section SAFC ensured a modest growth for the company although its “weak” research business in the US and the EU has stunted any drastic figures, according to...
25-Jul-2012 - Aegis Therapeutics has been granted a US patent for a novel formulation method and excipient that it claims reduces the risk of oxidative damage during MAb production and storage.
24-Jul-2012 - Four of the biggest pharma manufacturing associations are calling for more patient awareness of the burgeoning issue of fake drugs sold on the internet.
24-Jul-2012 - A House subcommittee has furthered legislation that would allow the sale of 1m CFC-propelled asthma inhalers.
24-Jul-2012 - Novasep has joined the growing number of manufacturers betting on the antibody drug conjugate (ADC) market with a €3m investment at its plant in Le Mans, France.
23-Jul-2012 - Ideal Cures has launched a ‘ready-to-use’ ER excipient designed to help mid-sized Pharmas cut costs and save time.
23-Jul-2012 - More support for IPEC Americas’ proposed excipient safety review process emerged last week with Colorcon saying it makes Pharmas more likely to use new excipients.
23-Jul-2012 - Expo Technologies has rebranded as Prozess Technologie and moved to a new HQ in St Louis, Missouri, US.
23-Jul-2012 - WAPMA and PMGMAN are calling on African Governments to pump more money into R&D in order to boost the continent’s pharmaceutical manufacturing sector.
19-Jul-2012 - Manufacturers of extended-release and long-acting (ER/LA) opioids have declined to comment on the impact of a class-wide REMS.
19-Jul-2012 - API maker Phyton Biotech LLC has been granted a CEP for the production of paclitaxel using plant cell-based fermentation.
18-Jul-2012 - API production in India will take a hit this week with plant closures for Aurobindo, Hetero Drugs, Divis Pharmaceuticals, and Sri Krishna Pharmaceuticals following allegations of environmental wrongdoing.
18-Jul-2012 - Biogrund and Beneo-Palatinit say new pill coating will help manufacturers cut process time.
18-Jul-2012 - Hollow nano shells capable of holding both cancer fighting drugs and immune-system boosters could be the solution to oncology’s greatest delivery riddle, according to Yale University researchers.
18-Jul-2012 - Fine chemicals were one of few positives for Albemarle in the second quarter according to the US chemicals firm’s latest results.
17-Jul-2012 - Drug quality in Mozambique looks set to improve following the creation of a national QA/QC testing laboratory.
17-Jul-2012 - Religion is playing a big part in increasing gelatine woes for Indian drugsmakers, according to Beroe.
17-Jul-2012 - Two major takeovers dominate the headlines this week with GSK finally securing its takeover of HGS and Par Pharmaceutical agreeing to be bought by private-equity firm TGS.
17-Jul-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest movers and shakers in the world of pharmaceuticals, including news from Daiichi Sankyo, Galenea and Lannett.
16-Jul-2012 - The Australian Government has announced a plan to improve how the TGA communicates with stakeholders just days after criticism about plans to increase fees.
16-Jul-2012 - Lonza says the migration of major customers’ R&D operations to Asia made protecting IP for its new expression system a must.
16-Jul-2012 - Unilife has been granted a US patent for its prefilled syringe technology just weeks after announcing a supply contract with an unnamed autoimmune disease-focused pharma.
16-Jul-2012 - AstraZeneca has bought compounds being developed for brain disorders from US biotech firm Link Medicine.
12-Jul-2012 - Lonza has launched a new version of its gene expression system that cuts weeks off the cell line development and construction process.
12-Jul-2012 - Dishman Pharmaceuticals has abandoned plans to set up a special economic zone (SEZ) citing law changes that make the project less attractive and unfavourable economics as the reasons for the decision. ...
12-Jul-2012 - ICH has countered claims that industry influence is detrimental by cutting commercial interests' power over regulators, a consultant said.
11-Jul-2012 - SOCMA’s BPTF says new fee laws under the FDA Safety and Innovation Act will improve drug quality and boost US manufacturing sector.
11-Jul-2012 - Prosonix aims to develop new treatments for respiratory diseases though an R&D accord formed with Imperial College London (ICL).
11-Jul-2012 - So far only Switzerland and Israel have asked to be included in the list of countries not required to provide written confirmation that plants making APIs destined for the EU...
10-Jul-2012 - Prokarium – a biotech company that was formerly part of UK CMO Cobra Biologics spin-out - has bought an oral vaccine technology from Emergent BioSolutions.
10-Jul-2012 - Albemarle has increased production capacity at its plant in Michigan, citing demand for custom and generic APIs as the driver.
10-Jul-2012 - An insomnia treatment linked to sleepwalking and sleep driving should stay on the market according to the Australian Therapeutic Good Administration (TGA).
09-Jul-2012 - Pharma execs are now spending as much time dealing with increasing levels of regulations as they spend on growing their businesses, according to KPMG.
09-Jul-2012 - The takeover of peptide-based actives developer Lipotec by industrial chemicals firm Lubrizol will not include the Spanish firm’s pharma business.
09-Jul-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest chops and changes in the pharmaceutical industry, including news from the EMA, Cipla, and MethylGene.
05-Jul-2012 - ‘Just add water’ as a preparation for cleaning the stand-in-place tech used to produce HP compounds, says Bosh’s Johannes Rauschnabel.
05-Jul-2012 - The EMA wants a debate on the extrapolation of clinical data to see if a framework is needed to govern this potential approach to reducing unnecessary research and letting industry...
05-Jul-2012 - The US FDA has published a 483 detailing the violations it observed during an inspection of stem cell firm Celltex Therapeutics in April and the document does not make for comfortable reading....
04-Jul-2012 - GlaxoSmithKline (GSK) tells in-Pharmatechnologist.com that it was 'mistakes' made a decade ago that led to this week's $3bn worth of criminal charges.
04-Jul-2012 - The US NIH has clarified its position on research animal welfare after its original statement raises concerns.
04-Jul-2012 - BASF has sold its chitosan biopolymers business to Norway-based Seagarden ASA continuing the divestiture of the non-core units it acquired as part of Cognis in 2010.
03-Jul-2012 - New Chinese SFDA draft guidelines make pharmaceutical firms more responsible for monitoring excipient quality and assessing suppliers.
03-Jul-2012 - New EU rules on pharmacovigilance will improve collection of data from post-authorisation safety and efficacy studies according to the EMA.
03-Jul-2012 - The implementation of single use technology in the biopharmaceutical fill and finish process has seen a massive uptick recently because of better industry understanding, according to Pall’s Bruce Rawlings.
02-Jul-2012 - API maker ScinoPharm is to invest in cancer drug and injectables capacity, citing current global shortages as a driver for its decision.
02-Jul-2012 - Bristol-Myers Squibb will pay $5.3bn for Amylin Pharmaceuticals in a move that furthers it and partner AstraZeneca’s efforts in diabetes and may herald next wave of Pharma consolidation.
02-Jul-2012 - in-PharmaTehcnologist.com presents its latest round-up of the new and changing faces of the pharmaceutical and biopharma world, including news from Transcept, Allegro and Sucampo.
02-Jul-2012 - A new hand-held testing device can help drugmakers determine if their stainless steel tech is prone to corrosion according to developer Koslow Scientific.
|« Previous month||Next month »|